Kolkicin
Kolkicin
Klass : 2
Visa all info
Skriv ut
Kontakta oss
Teva. Colrefuz Produktresumé. Läkemedelsverket [www]. [updated 2023-02-20, cited 2025-01-29].
Indraratna PL, Virk S, Gurram D, Day RO. Use of colchicine in pregnancy: a systematic review and meta-analysis. Rheumatology (Oxford). 2018;57(2):382-387.
Ofir D, Levy A, Wiznitzer A, Mazor M, Sheiner E. Familial Mediterranean fever during pregnancy: an independent risk factor for preterm delivery. Eur J Obstet Gynecol Reprod Biol. 2008;141(2):115-8.
Ben-Chetrit E, Levy M. Reproductive system in familial Mediterranean fever: an overview. Ann Rheum Dis 2003;62:916-919.
Iskender D, Kara O, Ozturk Kaymak A, Daglar HK, Kirbas A, Iskender CT et al. Association between basal proteinuria levels and pregnancy outcomes in familial Mediterranean fever. J Obstet Gynaecol. 2020;40(8):1102-1105.
Diav-Citrin O, Shechtman S, Schwartz V, Avgil-Tsadok M, Finkel-Pekarsky V, Wajnberg R et al. Pregnancy outcome after in utero exposure to colchicine. Am J Obstet Gynecol. 2010;203(2):144e1-6.
Ben-Chetrit E, Ben-Chetrit A, Berkun Y, Ben-Chetrit E. Pregnancy outcomes in women with familial Mediterranean fever receiving Colchicine: Is amniocentesis justified?. Arthrtis Care and Research 2010;62; 143-148. 2010.
Rabinovitch O.Zemer D. Kukia E. Sohar E. Mashiach S. Colchicine treatment in conception and pregnancy: two hundred thirty-one pregnancies in patients with familial Mediterranean fever. Am J Reprod Immunol 1992;28:245-6.
Berkenstadt M, Weisz B, Cuckle H, Di-Castro M, Guetta E, Barkai G. Chromosomal abnormalities and birth defects among couples with colchicine treated familial Mediterranean fever. Am J Obstet Gynecol 2005;193:1513-6.
UK Teratology Information Service (UKTIS). Use of colchicine in pregnancy September 2021 Verion 1. UKTIS [www]. [cited 2024-10-23].
Singer A, Grinshpun-Cohen J, Sagi-Dain L. Colchicine treatment increases the risk for fetal chromosomal aberrations-an observational study and systematic literature review. Rheumatology (Oxford). 2021;60(5):2342-2347.
- Teva. Colrefuz Produktresumé. Läkemedelsverket [www]. [updated 2023-02-20, cited 2025-01-29].
- Indraratna PL, Virk S, Gurram D, Day RO. Use of colchicine in pregnancy: a systematic review and meta-analysis. Rheumatology (Oxford). 2018;57(2):382-387.
- Ofir D, Levy A, Wiznitzer A, Mazor M, Sheiner E. Familial Mediterranean fever during pregnancy: an independent risk factor for preterm delivery. Eur J Obstet Gynecol Reprod Biol. 2008;141(2):115-8.
- Ben-Chetrit E, Levy M. Reproductive system in familial Mediterranean fever: an overview. Ann Rheum Dis 2003;62:916-919.
- Iskender D, Kara O, Ozturk Kaymak A, Daglar HK, Kirbas A, Iskender CT et al. Association between basal proteinuria levels and pregnancy outcomes in familial Mediterranean fever. J Obstet Gynaecol. 2020;40(8):1102-1105.
- Diav-Citrin O, Shechtman S, Schwartz V, Avgil-Tsadok M, Finkel-Pekarsky V, Wajnberg R et al. Pregnancy outcome after in utero exposure to colchicine. Am J Obstet Gynecol. 2010;203(2):144e1-6.
- Ben-Chetrit E, Ben-Chetrit A, Berkun Y, Ben-Chetrit E. Pregnancy outcomes in women with familial Mediterranean fever receiving Colchicine: Is amniocentesis justified?. Arthrtis Care and Research 2010;62; 143-148. 2010.
- Rabinovitch O.Zemer D. Kukia E. Sohar E. Mashiach S. Colchicine treatment in conception and pregnancy: two hundred thirty-one pregnancies in patients with familial Mediterranean fever. Am J Reprod Immunol 1992;28:245-6.
- Berkenstadt M, Weisz B, Cuckle H, Di-Castro M, Guetta E, Barkai G. Chromosomal abnormalities and birth defects among couples with colchicine treated familial Mediterranean fever. Am J Obstet Gynecol 2005;193:1513-6.
- UK Teratology Information Service (UKTIS). Use of colchicine in pregnancy September 2021 Verion 1. UKTIS [www]. [cited 2024-10-23].
- Singer A, Grinshpun-Cohen J, Sagi-Dain L. Colchicine treatment increases the risk for fetal chromosomal aberrations-an observational study and systematic literature review. Rheumatology (Oxford). 2021;60(5):2342-2347.